The Society of Diagnostic Medical Sonography (SDMS) announces a white paper on implementing a liver contrast program in the sonography laboratory.
In 2016 the FDA approved CEUS to image and characterize liver lesions as benign or malignant using gray-scale sonography. The technique includes the intravenous (IV) administration of a gas microbubble that the vascular system disperses to the liver, thus enabling liver lesion characterization. With the inclusion of CEUS to live imaging protocols, interpreter accuracy has been shown to improve to 88% over a baseline of 35% with gray-scale sonography alone.
The white paper details how CEUS works, the planning required to (read more…)